Michael Margolis: evaluation

Transcript context

…Which is how everyone always describes what product-market fit feels like. You just know it. If it's not obvious, then you don't have it. Okay. Michael, we did a lot of good work here. We've gone through the entire process, solved everyone's problems. I'm going to skip the lighting round just to keep this episode shorter. Is there anything else that you want to leave listeners with before we wrap up? One thing I've been thinking about and recently getting to experiment with, which I'm pretty excited about, is how to apply these methods in biotech. So a big piece of the GV portfolio is in biotech, developing new therapies, new treatments. That's a very different-looking kind of business than a lot of digital enterprise, consumer kind of products that I work with. What I think is really interesting is as I work more with those people... And so those are years, right? And they're doing science, so nobody's calling me when they're doing science. They don't need that help. They get to a point where there is some productization of it. You need to figure out like, "Oh, actually, how is this going to fit into a physician's workflow? How will patients react to this relative to some other possible treatment or other things that are out there? How do we encourage more people to accrue onto a clinical trial? How do we think about a clinical trial as a product and streamline that and make sure we're targeting the right people and increasing the number of people who are getting on there?" So what's been interesting is as I work with teams... I mean, talk about expert teams. As I talk to people who come from that tradition, I don't know what else to describe it, is they're doing similar work, but they don't seem to describe themselves as product managers. They have other kinds of titles. They come from like patient education, they have these other titles, but they're doing similar kinds of work. But they come from this other place, and so it's really... And they talk about TPPs, target product profiles. It's like this different language and this different world to me, but it's the same things, the same methods and the same stuff. So the idea of bringing some of these methods there, as I've been getting to do more recently, is really exciting to me because it feels like there's a... Partly, it feels a little greenfield, and partly, it just feels like the impact there is huge for some of those things. So that's something that I've just been thinking a lot about recently, is just kind of excited about those kind of opportunities. And also just kind of curious, I don't know, to hear from some of your listeners if they're doing some of this in those spaces. This is a good segue to two final questions that I ask everyone, so perfect. One is just share where people can find your book if they want to go deeper, if they want to practice it themselves. And also, do they reach out if they want to work with you on this sort of thing? So just share what folks can do if they want to learn more. And then, coming back to what you just said, how can listeners be useful to you, maybe share cool biotech stuff?…

Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.